Perspective Therapeutics, Inc.CATXNYSE
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank36
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P36
Within normal range
vs 5Y Ago
-1.7x
Contraction
Streak
2 yr
Consecutive growthAccelerating
PeriodValue
2025-30.98%
2024-91.41%
2023-204.51%
2022-56.39%
2021-147.86%
202017.78%
201928.75%
20189.19%
20173.39%
2016-43.08%